Gynecologic cancer
12 articles shown
Facing a Risk-Reducing Oophorectomy Before Natural Menopause: What Surgical Menopause Changes, and How to Plan Ahead for Bone and Heart Health
For people facing risk-reducing salpingo-oophorectomy before natural menopause after a BRCA finding: how surgical menopause differs from natural menopause, which short-term symptoms and long-term bone and cardiovascular issues are monitored, and how hormone and non-hormonal options, lifestyle steps and baseline tests are typically planned with a care team.
When Two Cycles of Chemo Make Her Feel Well Again — Understanding Interval Debulking Surgery and the Cancer You Cannot See
Explains why surgery may still be recommended in advanced ovarian cancer even when a patient feels dramatically better after neoadjuvant chemotherapy — covering the difference between symptom relief and remaining disease, the purpose and timing of interval debulking surgery, prehabilitation before an operation, cautions about substituting complementary care for the treatment schedule, and questions to bring to clinic.
When the Fever Keeps Coming Back After the First Chemotherapy Cycle — Why a Temperature That Drops With Fever Medicine Is Not the Same as Getting Better
Fever arising 7–14 days after a first chemotherapy cycle coincides with the neutrophil nadir and may represent febrile neutropenia, a time-sensitive emergency. This article explains why a temperature that falls with antipyretics is not the same as resolution, why fever can recur after treatment in the emergency department, how to keep a useful home fever log, and which signs warrant immediate contact with the care team.
When You Finish Chemo but Are Advised to Keep Taking a Pill — Understanding Maintenance Therapy, PARP Inhibitors, and How Biomarkers Like BRCA and HRD Guide Ovarian Cancer Treatment
A plain-language guide to what maintenance therapy means in ovarian cancer, how biomarkers such as BRCA and HRD help choose treatments like PARP inhibitors, and how to keep new-drug news in perspective.
When ovarian cancer returns 'within six months' — understanding why the time to recurrence separates 'platinum-sensitive' from 'platinum-resistant' disease
A plain-language explanation of platinum-based chemotherapy for high-grade serous ovarian cancer and why the time from finishing treatment to recurrence (the platinum-free interval) is used to distinguish 'platinum-sensitive' from 'platinum-resistant' disease. It clarifies that 'resistant' is not the patient's fault nor the end of treatment, and outlines what to discuss with a care team when choosing next steps.
When Chemo Is 'Weekly for Three Weeks, Then a Week Off' — Understanding Why Treatment Runs in Cycles and What the Rest Week Does
A plain-language look at why chemotherapy runs in cycles, what the rest week does for recovery and blood counts like neutrophils, how single-drug and combination regimens differ, and which side effects to watch for and report.
When Blood Sugar Swings During Cancer Treatment — Why Sleep, Stress, and Hormones Move Your Glucose, and the Diabetes Screenings (Eyes, Kidneys, Feet) That Are Easy to Miss
Why blood sugar becomes erratic during cancer treatment — sleep, hormonal shifts, steroids, and stress — the role of rest, and the diabetes complication screenings (eyes, kidneys, feet) that are easy to miss.
When Standard Treatments Run Out and a Clinical Trial Is Suggested — Understanding Eligibility Screening, the Enrollment Process, and Questions Worth Asking
A plain-language guide to what happens when a clinical trial is suggested after standard treatments: eligibility screening and biopsy, what trial phases and randomization mean, the informed-consent process and your right to withdraw, and questions worth asking your team.
After Ovarian Cancer Treatment, Hoping to Stay Recurrence-Free: How Follow-Up Works and How to Live Well Alongside the Fear of Recurrence
How follow-up after ovarian cancer treatment is structured (symptom review, CA-125, imaging), how to read markers as a trend, which symptoms to report, and how to rebuild daily life while living with the fear of recurrence.
When Blood Pressure Suddenly Climbs and Your Head Pounds During Chemotherapy — Why Some Cancer Drugs Raise Blood Pressure and How to Get It Managed
Blood pressure can rise during cancer treatment, especially with anti-angiogenic and targeted drugs. This piece explains why, how to track readings at home, how to arrange a temporary blood pressure medicine while keeping your oncology team informed, and the warning signs that call for the emergency room.
When Platelet Counts Keep Falling During Chemoradiation — Understanding Bone Marrow Suppression and the Wish for a 'Food That Fixes It'
Why platelets often fall during combined chemotherapy and radiation (bone marrow suppression), why no single food quickly fixes the count, warning signs of bleeding, and how treatment schedules are safely adjusted.
Before a Hysterectomy: Understanding Surgical Options, Recovery, and How Final Pathology Shapes What Comes Next
A plain-language overview of hysterectomy types and surgical approaches, recovery, and how the final pathology report one to two weeks after surgery determines whether additional treatment such as chemotherapy or radiation is needed.